High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden-Reference-Cited by-同舟云学术

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

Published:2014-02-21 Issue:5 Volume:92 Page:377-381
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Kozlowski Piotr¹,Åström Maria¹,Ahlberg Lucia²,Bernell Per³,Hulegårdh Erik⁴,Hägglund Hans³,Karlsson Karin⁵,Markuszewska-Kuczymska Alicja⁶,Tomaszewska-Toporska Beata⁵,Smedmyr Bengt⁷,Amini Rose-Marie⁸,Hallböök Helene⁷,

Affiliation:

1. Hematology Section; Department of Medicine; Örebro University Hospital; Örebro Sweden

2. Department of Hematology; University Hospital of Linköping; Linköping Sweden

3. Karolinska University Hospital; Stockholm Sweden

4. Department of Hematology and Coagulation; Sahlgrenska University; Göteborg Sweden

5. Department of Hematology; Skåne University Hospital; Lund Sweden

6. Department of Hematology; Cancer Center; University Hospital; Umeå Sweden

7. Department of Hematology; Uppsala University; Uppsala Sweden

8. Department of Immunology, Genetics and Pathology; Uppsala University; Uppsala Sweden

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12269/fullpdf

Reference15 articles.

1. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993);Marks;Blood,2009

2. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies;Gokbuget;Blood,2012

3. High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia;Hallbook;Br J Haematol,2002

4. Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia;Kantarjian;J Clin Oncol,2000

5. Population-based analyses in adult acute lymphoblastic leukemia;Juliusson;Blood,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDH2-mutated near ETP-ALL with aggressive leukemia cutis and brisk response to venetoclax and decitabine;Leukemia Research Reports;2024

2. Multi-omics integration reveals potential stage-specific druggable targets in T-cell acute lymphoblastic leukemia;Genes & Diseases;2023-04

3. Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia;International Journal of Hematologic Oncology;2023-03

4. Cytogenetic and molecular characteristics and outcomes of adult patients with early T‐cell precursor acute lymphoblastic leukemia;European Journal of Haematology;2022-10-18

5. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center;Leukemia Research;2022-08